~65%
of analyst 12-month price targets are missed. The average stock doesn't reach the analyst's forecast — it falls short.

The Real Accuracy Rate: What the Numbers Say

Every year, Wall Street publishes price targets for thousands of stocks. Analysts at Goldman Sachs, Morgan Stanley, JP Morgan, and dozens of other firms set 12-month forecasts that their institutional clients use to inform billion-dollar decisions. But how accurate are those forecasts?

The answer, consistently across decades of data: not very.

According to FactSet, Bloomberg Intelligence, and CXO Advisory Group — which track analyst performance independently — the median 12-month price target accuracy rate is approximately 34–36%. That means analysts are wrong roughly twice as often as they're right.

Source Time Period Accuracy Rate How It's Measured
Academic Meta-Analysis (50+ studies) 1990–2023 34.8% Target met or exceeded at 12 months
Bloomberg Intelligence 2020–2024 32–36% Target met or exceeded at 12 months
FactSet 2020–2024 ~34% Target met or exceeded at 12 months
CXO Advisory Group 2015–2024 35.7% Target met or exceeded at 12 months
TipRanks 2020–2024 34–38% Positive return within 12 months
Random chance baseline Theoretical 50% Random guessing
Why the gap below 50%? Analysts are systematically optimistic — they set most price targets above current levels. That structural bullishness means stocks regularly fail to reach their targets, dragging the hit rate below random chance.

The Optimism Bias: Why Analysts Are Wrong More Often Than Not

There's a structural reason analysts miss targets more often than they hit them. The investment banking business creates a conflict of interest that skews analyst research in a consistently bullish direction.

Here are the numbers: approximately 55–60% of all analyst ratings are "Buy" or "Outperform." Only about 5–8% are "Sell" or "Underperform." The rest fall in between. For every one analyst willing to say "Sell," there are roughly 8–10 saying "Buy."

This isn't because stocks are genuinely 6–7 times more likely to go up than down. It's because:

1. Investment banking relationships. The brokers who employ equity research analysts also do IPOs, follow-on offerings, and M&A advisory. A "Sell" rating on a company's stock makes it harder for the bank's dealmakers to win business from that company. Analysts know this.

2. Access to management. Analysts who write positive research get better access to company executives for interviews, earnings calls, and management meetings. Writing a "Sell" on a company tends to close that door.

3. Retail investor audience. Negative research doesn't generate subscription revenue. The buy-side firms that subscribe to broker research tend to hold long positions — they need ideas, not warnings.

The result is a systematic upward bias in price targets. When you set 90% of your targets above current prices, you guarantee that the majority of them will miss — not because you lacked skill, but because the deck was stacked in that direction from the start.

Key Insight

When a stock misses its 12-month price target, it's usually not because the analyst was wrong — it's because the target was set optimistically above where the stock was likely to trade in the first place. Understanding this bias is more useful than trying to evaluate analyst skill.

Accuracy Varies by Sector — Some Analysts Are Better Than Others

Not all analyst calls are equally unreliable. The data shows meaningful variation across sectors, suggesting that some industries are simply harder to forecast than others.

Sector 12-Month Accuracy Why It Varies
Utilities 40–45% Low volatility, predictable cash flows, stable regulation
Healthcare (non-biotech) 38–42% Stable fundamentals, predictable revenue cycles
Consumer Staples 37–42% Defensive, lower volatility, pricing power
Financials 33–37% Interest rate sensitivity, economic cycle dependency
Consumer Discretionary 28–33% Consumer spending volatility, discretionary demand
Energy 26–32% Commodity price swings, geopolitical risk
Technology 25–30% Fast disruption, product cycles, multiple expansion
Materials 25–30% Commodity-linked, macro sensitivity

Technology analysts have the worst track record. Part of that is structural — the sector experiences faster disruption, more frequent earnings surprises, and wider valuation swings. But even within technology, large-cap names with strong analyst coverage (think Apple, Microsoft, Nvidia) are more predictable than mid-cap software companies or semiconductor names.

Market Cap Matters: Big Stocks, Better Accuracy

Coverage quality is a significant driver of price target accuracy. Mega-cap stocks — Apple, Microsoft, Amazon — are covered by 20+ analysts, each with a full team of associates doing deep-dive modeling. Small-cap names often have 2–3 analysts covering them, if any at all.

Market Cap 12-Month Accuracy Coverage Notes
Mega-cap ($200B+) 42–48% 20+ analysts, deep coverage, rich data
Large-cap ($10B–$200B) 35–40% Good coverage, solid information flow
Mid-cap ($2B–$10B) 28–34% Thinner coverage, less institutional interest
Small-cap (<$2B) 18–25% Minimal coverage, wide information gaps
Micro-cap (<$300M) 10–15% Essentially random — nearly no institutional coverage

This is one of the most practically important findings: if you're investing in small-cap or micro-cap stocks, analyst price targets are nearly useless. The coverage is too thin, the information is too sparse, and the price targets are essentially guesses.

The Time Horizon Problem: Why Shorter Targets Are More Accurate

Accuracy degrades as the time horizon stretches. This shouldn't be surprising — the further out you forecast, the more unknown variables accumulate. But the magnitude of the degradation is striking.

Time Horizon Typical Accuracy
1-month ~50–55%
3-month ~42–47%
6-month ~38–42%
12-month ~32–38%
24-month ~25–30%
36-month ~20–25%

The average absolute error on a 12-month price target is roughly 20–30% — meaning the stock typically ends up 20–30% above or below where the analyst forecast. That's a wide enough range that a "correct" price target and a "wrong" one can look identical in hindsight.

Are Star Analysts Different?

Institutional Investor magazine publishes an annual "All-America Research Team" list, naming the top-ranked analysts in each sector. TipRanks ranks analysts by their historical performance. Some investors treat these lists as a signal of superior skill.

The data is more complicated than the rankings suggest:

Top-ranked analysts do outperform. Barron's All-Stars and TipRanks top-ranked analysts show 12-month accuracy of roughly 45–55% — meaningfully above the median, though still below random chance due to their systematic bullishness.

But persistence is weak. Analysts who rank in the top 10% one year have only a modest chance of repeating that performance the next year. The best single-year performers tend to be due for mean reversion — their rankings reflect some skill, but also a meaningful amount of luck.

CXO Advisory Group's annual tracking shows that roughly 60% of the prior year's top-performing analysts drop to below-median performance within 3 years. Skill exists, but it's swamped by noise and mean reversion.

Practical implication: Following star analyst rankings is a reasonable signal — but treat it as a starting point for research, not a shortcut to better returns. The "best" analyst in a category still misses more targets than they hit.

What Actually Moves Markets After a Price Target

Despite the poor accuracy record, analyst ratings and price targets still matter — just not in the way most people think. The rating itself is less important than the reaction to the rating.

When an analyst issues a new price target — whether up or down — the immediate market reaction tells you something about institutional conviction. A stock that gaps up 3% on an upgrade and holds that level has institutional buyers behind it. A stock that gaps up 1% and immediately gives it back is telling you the upgrade isn't moving the needle.

The price target itself is the forecast. The stock's behavior in the days and weeks following the release is the market's verdict on that forecast. That's why real-time alerts on rating changes and price target revisions matter — you're not trying to predict what the analyst will say, you're watching how the market responds to what they said.

How to Use Analyst Price Targets Effectively

The goal isn't to ignore analyst research — it's to use it correctly. Here's what that looks like in practice:

1. Treat accuracy as a probability, not a prediction. A price target isn't a guarantee. It's the analyst's best estimate given current information. What matters is whether the market's reaction confirms or contradicts that estimate.

2. Watch for consensus signals. One analyst raising a price target is noise. Five analysts raising price targets on the same stock within a short window is a signal. Consensus changes from multiple firms are where institutional money actually moves.

3. Contextualize accuracy by sector and cap. A price target on a mega-cap utility stock is more credible than one on a small-cap technology company. Factor that into how much weight you give the call.

4. Focus on revision signals, not absolute levels. Whether the price target is "right" at any given moment matters less than whether it's moving. A price target revision — up or down — is a real-time signal that something has changed in the analyst's view.

5. Track the reaction, not just the announcement. An upgrade that the market ignores is different from one that moves the stock. Use TargetPing to monitor when analysts change their views and watch how the market responds in the hours and days that follow.

The Bottom Line

Analyst price targets are wrong roughly 2 out of every 3 times. That fact isn't a knock on analyst research — it's a structural feature of a system that's built on optimistic bias, banking conflicts, and genuine forecasting difficulty.

The useful signal isn't whether a single analyst's target is "right." It's what happens across the market when dozens of analysts simultaneously update their views on a stock you follow. That's a high-conviction signal — one that tells you something real about how Wall Street's consensus is shifting.

TargetPing monitors 10,000+ stocks for exactly these signals — analyst upgrades, downgrades, and price target revisions. Get alerts when the consensus moves, so you can watch the market's reaction in real time.

Track analyst price target changes as they happen

TargetPing monitors Wall Street analyst activity on 10,000+ stocks and delivers real-time alerts when ratings or price targets change. Start free — no credit card required.

Start Free — Get Real-Time Alerts